Skip to main content

Prescription medicine

Trifarotene Brand names: Aklief

Trifarotene (Aklief) is a prescription medicine with an FDA approval on record since 2019. No generic is listed; pharmacies paid $16.36 per gram (Aklief 0.005% cream) in the October 7, 2026 NADAC survey.

  • No generic listed

Check it at the source: the trifarotene FDA label on DailyMed (effective September 16, 2024, Galderma Laboratories, L.P.); the NDA 211527 record on Drugs@FDA; every trifarotene label on DailyMed.

Highlights of the record

FDA label of September 16, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026

Used for

From the label: indications and usage

AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.

Forms and strengths

Cream.

On the market

Earliest approval on file
October 4, 2019 Aklief, Galderma Labs Lp; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
1 of which 0 under generic applications, 1 under brand applications, repackagers included
Last listed patent
May 30, 2033 Aklief cream; not a generic launch date

Supply and safety

Pharmacy cost (NADAC)
$16.36 per gram Aklief 0.005% cream
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
180 through July 30, 2026

What is trifarotene used for?

From the label: indications and usage

AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. AKLIEF Cream is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.

Conditions named in the indications of trifarotene's FDA labels, with every medicine labeled for each:

FDA pharmacologic class: Retinoid.

Source: FDA drug label (AKLIEF), Galderma Laboratories, L.P., effective September 16, 2024 (SPL set 62d910db-85a6-4696-b69b-4bd2f3080cfc), via openFDA; the full label on DailyMed

Is there a generic for trifarotene (Aklief)?

No generic trifarotene is approved (Drugs@FDA, October 8, 2026).

The Orange Book lists 3 patents for Aklief cream: the compound patent runs to July 19, 2031, and the last listed entry to May 30, 2033. A patent or exclusivity date is not the date a generic goes on sale: court cases and settlements move it either way.

  • 2019 earliest approval on file
  • 2033 last listed patent

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do pharmacies pay for trifarotene (Aklief)?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $16.36 per gram (Aklief 0.005% cream), up 4% from $15.71 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

  • Aklief 0.005% cream (brand)
$16.36
$15.68
May 2025October 2026
NADAC per unit, October 7, 2026
Strength and formBrand or genericPharmacy cost30 tablets, or one pen or vial12-month change
Aklief 0.005% creamBrand$16.36 per gramn/a+4%

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What does the trifarotene label say about other medicines?

The trifarotene label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Levonorgestreldrug interactionsDRUG INTERACTIONS Topical application of AKLIEF Cream is not expected to affect the circulating concentrations of oral hormonal contraceptives containing ethinyl estradiol and levonorgestrel.

Check trifarotene against other medicines

Source: FDA drug label (AKLIEF), Galderma Laboratories, L.P., effective September 16, 2024 (SPL set 62d910db-85a6-4696-b69b-4bd2f3080cfc), via openFDA; the full label on DailyMed

What do FAERS reports show for trifarotene?

The FDA Adverse Event Reporting System holds 180 reports that list trifarotene among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 2 are coded as a death and 9 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Erythema (named in the label)28
  • Acne (a use or a product term, not a reaction)17
  • Skin Burning Sensation17
  • Urinary Retention16
  • Dry Skin15
  • Mydriasis15
  • Skin Exfoliation14
  • Skin Irritation (named in the label)13

Side effects: the label's list and every FAERS reaction

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What else is labeled for the same conditions as trifarotene?

15 other medicines are given the same way (topical) and in the same FDA class as trifarotene or labeled mainly for the same use (acne), the same class first. Acne lists all 26 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.

MedicineShared indicationGeneric labelers (topical)Pharmacy costShortage
TretinoinAcne19 labelers$0.506 per gram 0.025% creamNo current entry
AdapaleneAcne34 labelers$0.504 per gram 0.3% gelNo current entry
Adapalene and benzoyl peroxideAcne11 labelers$0.626 per gram 0.3-2.5%No current entry
TazaroteneAcne6 labelers$6.11 per gram 0.1% gelNo current entry
Clindamycin and tretinoinAcne3 labelers$3.91 per gram 1.2%-0.025%No current entry
Benzoyl peroxide and tretinoinAcnenone listed$31.66 per gram 0.1%-3% cream pumpNo current entry
Adapalene and benzoyl peroxide and clindamycinAcnenone listedn/aNo current entry
Salicylic acidAcnenone listed$0.102 per patch Callus removers patchNo current entry

Every medicine labeled for the same conditions as trifarotene

Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)

What next?

Alternatives to trifarotene
15 medicines for the same use
Other retinoids
the pharmacologic class, with prices and generics
Trifarotene side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other